.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Dow
Novartis
Daiichi Sankyo
Cipla
Merck
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Argus Health

Generated: September 24, 2017

DrugPatentWatch Database Preview

DOXY 200 Drug Profile

« Back to Dashboard

Which patents cover Doxy 200, and what generic Doxy 200 alternatives are available?

Doxy 200 is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in DOXY 200 is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-one suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for Tradename: DOXY 200

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list3,521
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXY 200 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
DOXY 200
doxycycline hyclate
INJECTABLE;INJECTION062475-002Dec 9, 1983RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Merck
US Army
Daiichi Sankyo
QuintilesIMS
Cipla
Chubb
US Department of Justice
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot